Lista de obras -

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma

artículo científico publicado en 2016

Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor

artículo científico publicado en 2015

Cancer-targeted oncolytic adenoviruses for modulation of the immune system

artículo científico publicado en 2017

Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans

artículo científico publicado en 2012

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

artículo científico publicado en 2015

Corrigendum to "Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma".

artículo científico publicado en 2016

Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models

artículo científico publicado en 2017

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models

artículo científico publicado en 2007

Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors

artículo científico publicado en 2015

GMCSF-armed vaccinia virus induces an antitumor immune response

artículo científico publicado en 2014

Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas

artículo científico publicado en 2017

Improving adoptive T cell therapy with adenoviruse armed with TNF-α and IL-2.

artículo científico publicado en 2015

Incomplete but infectious vaccinia virions are produced in the absence of oncolysis in feline SCCF1 cells

artículo científico publicado en 2015

Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models

artículo científico publicado en 2012

MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma

artículo científico publicado en 2015

MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver

artículo científico publicado en 2013

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma

artículo científico publicado en 2014

Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance.

artículo científico publicado en 2015

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy

artículo científico publicado en 2012

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

artículo científico publicado en 2015

PROX1 is a transcriptional regulator of MMP14.

artículo científico publicado en 2018

Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity

artículo científico publicado en 2010

Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains

artículo científico publicado en 2012

Replication competent Semliki Forest virus prolongs survival in experimental lung cancer

artículo científico publicado en 2008

Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles

artículo científico publicado en 2014

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting

artículo científico publicado en 2016

T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma

artículo científico publicado en 2016

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

artículo científico publicado en 2015

Tumor Restrictions to Oncolytic Virus

artículo científico publicado en 2014

Lista de obras de

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma

Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor

Cancer-targeted oncolytic adenoviruses for modulation of the immune system

Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Corrigendum to "Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma".

Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles

Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models

Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors

GMCSF-armed vaccinia virus induces an antitumor immune response

Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas

Improving adoptive T cell therapy with adenoviruse armed with TNF-α and IL-2.

Incomplete but infectious vaccinia virions are produced in the absence of oncolysis in feline SCCF1 cells

Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models

MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma

MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma

Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance.

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

PROX1 is a transcriptional regulator of MMP14.

Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity

Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains

Replication competent Semliki Forest virus prolongs survival in experimental lung cancer

Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting

T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Tumor Restrictions to Oncolytic Virus